Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Growth Metrics

Others

Odyssey Health (ODYY) Asset Writedowns and Impairment (2018)

Odyssey Health has reported Asset Writedowns and Impairment over the past 1 years, most recently at $131447.0 for Q1 2018.

For Q1 2018, Asset Writedowns and Impairment changed N/A year-over-year to $131447.0; the TTM value through Jan 2019 reached $131447.0, changed 0.0%, while the annual FY2024 figure was $13.0 million, N/A changed from the prior year.
Asset Writedowns and Impairment for Q1 2018 was $131447.0 at Odyssey Health.
Over five years, Asset Writedowns and Impairment peaked at $131447.0 in Q1 2018 and troughed at $131447.0 in Q1 2018.